Global & Public Health (all articles) | Page 29 of 252 | Links Medicus Content Curation & Alerts in Medicine

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa.

25 Jan, 2022 | 09:41h | UTC

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study – The Lancet

Commentary: Omicron severity: milder but not mild – The Lancet

Commentary on Twitter

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in S. Africa, Lancet. Individuals with Omicron vs previous infections 80% lower odds of being admitted to hospital, 70% lower odds of severe disease than Deltahttps://t.co/528NWfKrDN

— Monica Gandhi MD, MPH (@MonicaGandhi9) January 23, 2022

COVID-19: endemic doesn’t mean harmless.

25 Jan, 2022 | 09:36h | UTC

COVID-19: endemic doesn’t mean harmless – Nature

[Preprint] Cohort study: Reduced risk of hospitalization associated with infection with SARS-CoV-2 Omicron relative to Delta.

25 Jan, 2022 | 09:40h | UTC

Reduced Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Relative to Delta: A Danish Cohort Study – SSRN / Preprints with The Lancet

Commentaries:

Danish report: lower risk of hospitalisation with Omicron – Copenhagen Post

Omicron has a 36% lower risk for hospitalization compared to Delta: Denmark study – Outbreak News Today

Commentary on Twitter

New Danish population-based cohort study confirms lower (36%, 95%CI 44%-25%) risk of hospitalization with Omicron compared with Delta.
The risk also seems to be reduced irrespective of vaccination status.

Pre-print can be found here: https://t.co/LfRrw1H3CY pic.twitter.com/Ql3zPyZyRE

— Anders Husby (@a_husby) January 20, 2022

We will be living with COVID for foreseeable future; but we can end acute phase of pandemic this year — WHO Director General.

25 Jan, 2022 | 09:34h | UTC

We Will be Living with COVID for Foreseeable Future; but We Can End Acute Phase of Pandemic this Year — WHO Director General – Health Policy Watch

Guidelines on Screen Time and Digital Wellness in Infants, Children and Adolescents – “children below 2 years age should not be exposed to any type of screen, whereas exposure should be limited to a maximum of one hour of supervised screen time per day for children 24-59 months age, and less than two hours per day for children 5-10 years age”.

25 Jan, 2022 | 09:30h | UTC

Indian Academy of Pediatrics Guidelines on Screen Time and Digital Wellness in Infants, Children and Adolescents

[Preprint] Omicron SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta.

25 Jan, 2022 | 09:37h | UTC

Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2) – medRxiv

Commentary on Twitter

In Portugal, Omicron hospitalizations were 75% reduced compared with Delta, risk adjusted. Vaccination reduced hospitalizations 84%, w/a booster 93%https://t.co/MvkfuF3mzx pic.twitter.com/zyk2INWNis

— Eric Topol (@EricTopol) January 23, 2022

Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study.

25 Jan, 2022 | 09:13h | UTC

Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study – EClinicalMedicine

Commentary on Twitter

A new study using data from the #GBD 2019 study estimated trends in congenital #heartdisease (CHD) mortality in 204 countries and territories over the past 30 years.

Read more here: https://t.co/6NtW0TYMAG pic.twitter.com/VLCU9OuOwx

— eClinicalMedicine – The Lancet Discovery Science (@eClinicalMed) January 14, 2022

European CDC on Omicron: “among Omicron cases reported to TESSy, 1.14% were hospitalised, 0.16% required ICU admission/respiratory support, and 0.06% died”.

24 Jan, 2022 | 08:54h | UTC

Weekly epidemiological update: Omicron variant of concern (VOC) – week 2 (data as of 20 January 2022) EU/EEA – European Centre for Disease Prevention and Control (ECDC)

Case-control study: 3 doses of mRNA vaccines were associated with reduced infections with SARS-CoV-2 Omicron and Delta variants compared to no vaccination or 2 doses.

24 Jan, 2022 | 08:56h | UTC

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants – JAMA

Editorial: Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach – JAMA

Commentaries: New data show booster doses protect against Omicron – CIDRAP

Boosters provide the best protection against Omicron variant, CDC studies show, raising new questions about what it means to be fully vaccinated – CNN

Related CDC Studies:

COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 – CDC Morbidity and Mortality Weekly Report

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 – CDC Morbidity and Mortality Weekly Report

Commentary on Twitter

Study suggests receipt of 3 doses of mRNA #COVID19 vaccine, vs 2 doses or being unvaccinated, was associated with protection against both the Omicron and Delta variants; higher odds ratios for Omicron suggest less protection for Omicron than for Delta. https://t.co/kOZh0fq5TL

— JAMA (@JAMA_current) January 21, 2022

WHO updated roadmap for prioritizing uses of COVID-19 vaccines.

24 Jan, 2022 | 08:49h | UTC

WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines – World Health Organization

Commentary: WHO: COVID boosters should start with most vulnerable – Associated Press

Commentary on Twitter (thread – click for more)

UPDATED: The Strategic Advisory Group of Experts (SAGE) have revised the Roadmap for Prioritising Uses of #COVID19 vaccines.

👉 https://t.co/FJFlMpBSSK pic.twitter.com/4SNH7ZpSwz

— World Health Organization (WHO) (@WHO) January 21, 2022

WHO advisers weigh in on COVID-19 boosters, Pfizer vaccine in younger kids.

24 Jan, 2022 | 08:35h | UTC

WHO advisers weigh in on COVID-19 boosters, Pfizer vaccine in younger kids – CIDRAP

WHO Technical Brief: Enhancing response to Omicron SARS-CoV-2 variant.

24 Jan, 2022 | 08:36h | UTC

Enhancing response to Omicron SARS-CoV-2 variant – World Health Organization

No amount of alcohol is good for the heart, says World Heart Federation.

24 Jan, 2022 | 08:23h | UTC

News Release: No amount of alcohol is good for the heart, says World Heart Federation

Report: The Impact of Alcohol Consumption on Cardiovascular Health: Myths and Measures – World Heart Federation

Commentary: No amount of alcohol is good for the heart, new report says, but critics disagree on science – CNN

Flying in the COVID-19 era: Science-based risk assessments and mitigation strategies on the ground and in the air.

24 Jan, 2022 | 08:32h | UTC

Flying in the COVID-19 Era: Science-based Risk Assessments and Mitigation Strategies on the Ground and in the Air – National Academies of Sciences, Engineering, and Medicine (free registration required)

Review: Health literacy interventions for secondary prevention of coronary artery disease.

24 Jan, 2022 | 08:12h | UTC

Health literacy interventions for secondary prevention of coronary artery disease: a scoping review – openheart

Opinion: COVID-19 will continue but the end of the pandemic is near.

21 Jan, 2022 | 10:16h | UTC

COVID-19 will continue but the end of the pandemic is near – The Lancet

Commentary on Twitter

.@IHME_UW's Chris Murray predicting the end of the pandemic is nigh
"More than 50% of the world will have been infected with omicron …[by] the end of March, 2022"
"After the omicron wave, COVID-19 will return but the pandemic will not."https://t.co/9NSw8lZuUe @TheLancet

— Eric Topol (@EricTopol) January 20, 2022

RCT: Immunogenicity and reactogenicity of different vaccine boosters after a first J&J vaccine.

21 Jan, 2022 | 10:12h | UTC

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming – New England Journal of Medicine

Commentary on Twitter

Trial examined effects of boosting with one of the three approved #COVI19 vaccines — AD26.COV2.S, mRNA-1273, or BNT162b2 — 3 mos after the primary vaccination. All increased neutralizing-antibody levels & T-cell responses; mRNA vaccines were higher. https://t.co/qkpQFvNliJ pic.twitter.com/MUfa1OEsLP

— NEJM (@NEJM) January 19, 2022

Opinion: Now that science has defanged Covid, it’s time to get on with our lives.

21 Jan, 2022 | 10:14h | UTC

Now that science has defanged Covid, it’s time to get on with our lives – The Guardian

Europe considers new COVID-19 strategy: Accepting the virus.

21 Jan, 2022 | 10:13h | UTC

Europe considers new COVID-19 strategy: Accepting the virus – Associated Press

[Preprint] COVID infection severity in children under 5 years old before and after Omicron emergence in the US.

21 Jan, 2022 | 10:04h | UTC

COVID infection severity in children under 5 years old before and after Omicron emergence in the US – medRxiv

Commentary: SARS-CoV-2 Omicron infections milder in children compared to Delta – News Medical

Editorial | Covid-19 vaccines and treatments: we must have raw data, now.

21 Jan, 2022 | 10:00h | UTC

Covid-19 vaccines and treatments: we must have raw data, now – The BMJ

News Release: Editors call for covid-19 vaccine and treatment data to be available for public scrutiny – The BMJ

WHO’s Emergencies expert group re-asserts stance against covid ‘vaccine passports’ for international travel.

21 Jan, 2022 | 10:02h | UTC

WHO’s Emergencies Expert Group Re-Asserts Stance Against COVID ‘Vaccine Passports’ for International Travel – Health Policy Watch

Is precision public health the future — or a contradiction?

21 Jan, 2022 | 09:31h | UTC

Is precision public health the future — or a contradiction? – Nature

Cluster Randomized Trial: A multifactorial falls prevention program in UK care homes reduced fall rates among older people and was cost effective.

21 Jan, 2022 | 09:21h | UTC

Multifactorial falls prevention programme compared with usual care in UK care homes for older people: multicentre cluster randomised controlled trial with economic evaluation – The BMJ

News Release: Falls in care homes can be significantly reduced with intervention, says new study – University of Nottingham

Commentary on Twitter

NEW RESEARCH: A falls prevention programme for older people in care homes, co-designed with care home staff & residents, that involved awareness raising, education, screening, decision & implementation support was associated with a reduction in falls rate https://t.co/wupI0LeAxj

— The BMJ (@bmj_latest) December 11, 2021